Navigation Links
CMMB Applauds America at Its Best as PEPFAR is Reauthorized by U.S. Government
Date:7/30/2008

WASHINGTON, July 30 /PRNewswire/ -- CMMB (Catholic Medical Mission Board), the leading U.S.-based Catholic charitable organization focused exclusively on global healthcare, praised the U.S. government's extension of the President's Emergency Plan for AIDS Relief (PEPFAR) through the year 2013, signed into law today by President Bush.

"The world sees America at our very best with this new five-year, $48 billion commitment," said CMMB President and Chief Executive Officer John F. Galbraith, who attended the bill-signing ceremony at the White House. "The U.S. government support means that we can continue to save lives today, while building healthcare capacity that will serve the world's poor far into the future."

CMMB has been a recipient of PEPFAR funds since the program was initiated in 2003. CMMB receives significant PEPFAR funding for healthcare services provided to AIDS patients, orphans and other vulnerable children suffering from the pandemic, and other recipients in countries such as Kenya, South Africa, Haiti, and Zambia. The new bill (HR 5501) directs that 10 percent of funding be directed to orphans and vulnerable children. CMMB recently expanded its operations in Kenya with the opening of a second office and with the creation of a Kenya-specific corps of volunteer healthcare professionals.

About CMMB: Founded in 1912 and rooted in the healing ministry of Jesus, Catholic Medical Mission Board works collaboratively to provide quality healthcare programs and services without discrimination to people in need around the world. Catholic Medical Mission Board is a nonprofit, religious, 501(c)(3) organization that provides services and delivers aid without regard to creed, race, sex, or national or political circumstance. Catholic Medical Mission Board is a non-governmental organization in consultative status with the Economic and Social Council (ECOSOC) of the United Nations. For more information, visit '/>"/>

SOURCE Catholic Medical Mission Board
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
2. Fairness Coalition Applauds Senate Passage of Mental Health Parity Bill
3. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
4. Cardiac Science Applauds Mass AED Training of Pittsburgh Educators
5. Coalition to Protect Floridas Drivers Applauds Governor Crist for Adding PIP to Special Session
6. AGD Applauds Congressional Support of SCHIP Reauthorization
7. Tobacco-Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking
8. Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation
9. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
10. California Alliance Applauds Governors Support of Group Home Reform for Foster Youth
11. ASGE Applauds News of Drop in Colorectal Cancer Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... McCullers, MD, was recently invited to submit a ... Reviews Microbiology , one of the world,s foremost ... disease specialist, and chair of the Department of ... Center, analyzed the epidemiology and microbiology of co-infections ... well as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
(Date:4/17/2014)... EcoHealth Alliance, a nonprofit organization that focuses on ... review today examining the current state of knowledge of ... for improved global surveillance strategies to combat the emergence ... Ebola in West Africa that has claimed the lives ... Liberia. According to the World Health Organization (WHO), ...
(Date:4/17/2014)... international research team led by Cesar A. Arias, M.D., ... at Houston (UTHealth) has identified a new superbug that ... report appeared in the April 17 issue of ... new superbug is part of a class of highly-resistant ... MRSA, which is a major cause of hospital and ...
Breaking Medicine News(10 mins):Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:New MRSA superbug emerges in Brazil 2
... the World; First Centers to Open ... France and China, Kenneth P. Moritsugu, M.D., Former Acting Surgeon General, Appointed to ... Lead Global ... today announced the establishment of the Johnson &,Johnson Diabetes Institute (JJDI) to transform diabetes ...
... IT Services Leader Will Provide Systems Operations, ... Military Health System Computing Environment, ARLINGTON, ... leading global,provider of information management and business ... awarded the Military Health System,Executive Information and ...
... MedPredict Market Research,a global provider of pharmaceutical ... report providing critical strategic insight,for pharma and biotech ... anxiety and,depression therapies. In this report, entitled ... physician experts from North America and Europe,discuss the ...
... and Oncology is pleased to announce that Stefanie LaRue of ... Circle Award winner. Ms. LaRue will be presented with her ... 2007, at 8:00 a.m. at the Los Angeles Convention Center ... 28 through November 1 in Los Angeles., The Survivor Circle ...
... existing regimen may help, researchers say , TUESDAY, Oct. ... as an added therapy, the epilepsy drug lamotrigine is ... , The 239 participants, aged 13 and older, were ... They were already taking one or two medications, but ...
... For the seventh,consecutive year West Coast Bank will partner ... the Heart of Doernbecher Auction, which,has raised over $2.5 ... tie event will be held at Portland Art Museum, ... Bank,s Executive Vice President of Commercial Banking Xandra,McKeown serves ...
Cached Medicine News:Health News:Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals 2Health News:Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals 3Health News:Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals 4Health News:Vangent, Inc. Awarded Contract to Support Military Health System's Executive Information and Decision Support Program 2Health News:New Report Provides Insight Into Developments in the Market for Anxiety and Depression Therapies 2Health News:LA breast cancer activist honored with Survivor Circle Award 2Health News:LA breast cancer activist honored with Survivor Circle Award 3Health News:Lamotrigine May Reduce Epilepsy Seizures 2Health News:West Coast Bank Will Sponsor the Heart of Doernbecher Auction at the Portland Art Museum, October 20, 2007 2
(Date:1/15/2014)... Jan. 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin ... provisional patent application concerning composition of matter, biological targets, ... tumor cell death.  This patent application ... stranded RNA molecules (VSRNAs) which interfere with the basic ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium Research ... market intelligence, the United States ... device markets will expand moderately through 2022, with ... In particular, increasing interest in drug-eluting beads (DEBs) ...
(Date:1/15/2014)... LAVAL, Quebec , Jan. 15, 2014  Valeant Pharmaceuticals ... VRX) announced that the applicable waiting period under the ... to the previously announced tender offer by its indirect ... the outstanding shares of common stock of Solta Medical, ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... Presented Along With Updated Phase 1 Colorectal Cancer ... Data at ... CHICAGO, June 1 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ... results,from its ongoing randomized Phase 2 clinical trial in patients ...
... Greater Than 50% Response Rate and 100% Disease Control Rate Observed ... Patients with Medullary Thyroid Cancer, ... encouraging new data from an ongoing phase 1 clinical trial of,XL184, ... with advanced malignancies. The maximum tolerated dose (MTD) for,XL184 has been ...
Cached Medicine Technology:Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer 2Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer 3Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer 4Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer 5Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 2Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 3Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 4Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 5Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO 6
The UniCel DxI 800 with its exceptional throughput, proven chemiluminescent technology, assay protocols like Access, Access 2, Synchron LXi 725 and load "on-the-fly" capability simplifies and automat...
... The Access immunoassay system ... access benchtop analyzer that ... assays, with panels that ... thyroid, infectious disease, blood ...
...
...
Medicine Products: